Mazanti-Andersen is Denmark’s oldest law firm and among the leading law firms in Denmark. We cover a variety of practice areas of relevance to the life science industry, including venture capital financing, regulatory matters, corporate M&A and dispute resolution.
In addition to many biotech companies, our clients include pharmaceutical companies, manufacturers of medical devices, venture funds and corporate VCs.
We have extensive experience in advising biotech companies on sourcing capital and have in recent years assisted in raising more than DKK 10 billion in proceeds and listed several biotech companies on Nasdaq Copenhagen and Nasdaq New York, including Forward Pharma and Ascendis Pharma.
With respect to pharmaceutical development, we are experienced in drafting and negotiating various types of agreements with industry players, including CMOs and CROs.
We regularly assist our clients in connection with negotiation and conclusion of license agreements, service, development and manufacturing agreements related to preclinical and clinical studies and in connection with manufacture of APIs and pharmaceutical preparations.
For further information, please visit www.mazanti.dk/en/areas/corporate-commercial/life-science/